← Open Payments lookup

LIUDMILA LOBACH: Open Payments

NPI 1962832808 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,155 in 45 payments from 11 companies in 2025. Trend: 2023 $748 · 2024 $751 · 2025 $1,155

Food & beverage: $1,155
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$254
Vanda Pharmaceuticals Inc.7$181
Janssen Pharmaceuticals, Inc5$162
Alkermes, Inc.8$136
ABBVIE INC.5$94
E.R. Squibb & Sons, L.L.C.3$87
Teva Pharmaceuticals USA, Inc.3$77
Almatica Pharma LLC3$64
Neurocrine BioSciences, Inc.2$58
Lundbeck LLC1$29

Products named: FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, LYBALVI, COBENFY, UZEDY.

Industry payments across PA — which companies pay providers there.